A method for the preparation of highly purified adeno-associated virus using affinity column chromatography, protease digestion and solvent extraction

被引:27
作者
Anderson, R [1 ]
Macdonald, I [1 ]
Corbett, T [1 ]
Whiteway, A [1 ]
Prentice, HG [1 ]
机构
[1] UCL, Royal Free & Univ Coll Med Sch, Dept Haematol, Bone Marrow Transplant Programme, London NW3 2PF, England
关键词
adeno-associated virus; purification; solvent extraction; protease digestion;
D O I
10.1016/S0166-0934(99)00150-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Recombinant adeno-associated virus (AAV) is becoming the vector of choice for many gene therapy protocols. There has been much recent progress made toward increasing AAV titres but a continuing problem in using AAV has been that it is relatively difficult to concentrate and purify. Traditional methods, such as caesium chloride (CsCl) gradients, have drawbacks, notably extended purification times and the ability to process only limited volumes. Where the target cells of interest require a high multiplicity of infection (MOI), or to complete in vivo experiments, there is a requirement for both the production of high titre and a large volume of virus. This is laborious to obtain using traditional methods. A simple technique is described here for purifying AAV, involving affinity chromatography, protease digestion and solvent extraction that retains both the high yields and titres obtained using CsCl gradients. In addition, this technique displays a fast throughput and may be used to purify AAV from larger volumes than CsCl gradients. The high yield and purity of these virus preparations has allowed us to achieve good levels of expression in the target cell types tested. The purification technique described here will be applicable to any protocol that requires high titre, high purity recombinant AAV (rAAV). (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:23 / 34
页数:12
相关论文
共 24 条
[1]   Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results [J].
Alexander, IE ;
Russell, DW ;
Miller, AD .
HUMAN GENE THERAPY, 1997, 8 (16) :1911-1920
[2]   Construction and biological characterization of an interleukin-12 fusion protein (Flexi-12): Delivery to acute myeloid leukemic blasts using adeno-associated virus [J].
Anderson, R ;
MacDonald, I ;
Corbet, T ;
Hacking, G ;
Lowdell, MW ;
Prentice, HG .
HUMAN GENE THERAPY, 1997, 8 (09) :1125-1135
[3]   PARVOVIRIDAE - 2ND REPORT [J].
BACHMANN, PA ;
HOGGAN, MD ;
KURSTAK, E ;
MELNICK, JL ;
PEREIRA, HG ;
TATTERSALL, P ;
VAGO, C .
INTERVIROLOGY, 1979, 11 (04) :248-254
[4]   High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors [J].
Chiorini, JA ;
Wendtner, CM ;
Urcelay, E ;
Safer, B ;
Hallek, M ;
Kotin, RM .
HUMAN GENE THERAPY, 1995, 6 (12) :1531-1541
[5]   Optimization of packaging of adeno-associated virus gene therapy vectors using plasmid transfections [J].
Chirico, J ;
Trempe, JP .
JOURNAL OF VIROLOGICAL METHODS, 1998, 76 (1-2) :31-41
[6]  
EINERHAND MPW, 1995, GENE THER, V2, P336
[7]   USE OF ADENO-ASSOCIATED VIRUS AS A MAMMALIAN DNA CLONING VECTOR - TRANSDUCTION OF NEOMYCIN RESISTANCE INTO MAMMALIAN TISSUE-CULTURE CELLS [J].
HERMONAT, PL ;
MUZYCZKA, N .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (20) :6466-6470
[8]   Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors [J].
Inoue, N ;
Russell, DW .
JOURNAL OF VIROLOGY, 1998, 72 (09) :7024-7031
[9]   CLONING OF INFECTIOUS ADENO-ASSOCIATED VIRUS GENOMES IN BACTERIAL PLASMIDS [J].
LAUGHLIN, CA ;
TRATSCHIN, JD ;
COON, H ;
CARTER, BJ .
GENE, 1983, 23 (01) :65-73
[10]   DEFECTIVE-INTERFERING PARTICLES OF THE HUMAN PARVOVIRUS ADENO-ASSOCIATED VIRUS [J].
LAUGHLIN, CA ;
MYERS, MW ;
RISIN, DL ;
CARTER, BJ .
VIROLOGY, 1979, 94 (01) :162-174